Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells

Cancer

Volumn 80, Issue 11, 1997, Pages 2068-2074

  Kaufmann, Roland ^a   Schafberg, Heiko ^a   Rudroff, Claudia ^a   Nowak, Götz ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

thrombin; HEp 2g; Protein kinase C; Thrombin receptor activating peptide

Indexed keywords

BISINDOLYLMALEIMIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CANCER GROWTH; DNA SYNTHESIS; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CALCIUM; CARCINOMA; DNA, NEOPLASM; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LARYNGEAL NEOPLASMS; PROTEIN KINASE C; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030691950     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2068::AID-CNCR5>3.0.CO;2-T     Document Type: Article

References (24)

1. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64:1057-68.
2. Nanevicz T, Ishii M, Wang L, Chen M, Chen J, Turck CW, et al. Mechanism of thrombin receptor agonist specifity. Chimeric receptors and complementary mutations identify an agonist recognition site. J Biol Chem 1995;270:21619-25.
3. Berndt M, Philipps D. Platelet membrane proteins: composition and receptor function. In: Gordon J, editor. Platelets in biology and pathology. Amsterdam: Elsevier/North Holland, 1981:43-7.
4. Glenn K, Carney D, Fenton J, Cunningham D. Thrombin active-site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem 1980;255:6609-16.
5. Bar-Shavit R, Mudd M, Wilner G, Mann K, Fenton JWII. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 1983;220:728-31.
6. Zacharski LR. Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants. Onkologie 1987;10:264-70.
7. Chahinian AP. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the cancer and leucemia group B. J Clin Oncol 1989;7:993-1002.
8. Nierodzik ML, Kajumo LR, Karpatkin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 1992;52:3267-72.
9. Wojtukiewicz MZ, Tang DG, Ben-Josef E, Nenaud C, Walz DA, Honn KV. Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res 1995;55:698-704.
10. Guillaume T, Sekhavat M, Rubinstein DB, Hamadan O, Syman ML. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. Cancer Res 1993;53:3139-44.
11. Hemmi S, Bohni R, Stark G, Di Marco F, Aguet M. A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in ; human cells. Cell 1994;76:803-10.
12. Sakai T, Ohta M, Furukawa Y, Saga Y, Aizawa S, Kawakatsu H, et al. Tenascin C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions. J Cell Physiol 1995;165:18-29.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
14. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-39.
15. Tsien RY. Fluorescence probes of cell signaling. Annu Rev Neurosci 1989;12:227-53.
16. Krüger H, Schröder W, Buchner K, Hucho F. Protein kinase C inhibition by calmodulin and its fragments. J Protein Chem 1990;9:467-73.
17. Alexander DR, Cantrell DA. Kinases and phosphatases in T-cell activation. Immunol Today 1989;10:200-5.
18. Huang KP. The mechanism of protein kinase C activation. Trends Neurosci 1989;12:425-32.
19. Norton KJ, Scarborough RM, Kutok JL, Escobedo M-A, Nannizzi L, Coller BS. Immunologic analysis of the cloned thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood 1993;82:2125-36.
20. Blackhart BD, Cuenco G, Toda T, Scaborough RM, Wolf DL, Ramakrishnan V. The anion-binding exosite is critical for the high affinity binding of the thrombin receptor. Growth Factors 1994;11:17-28
21. Harmon JT, Jamieson GA. The glycocalicin portion of platelet glycoprotein Ib express both high and moderate affinity receptor sites for thrombin. J Biol Chem 1986;261:3184-8.
22. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982;257:859-64.
23. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980;21:37-45.
24. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, et al. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993;54:793-806.